SCHEMBL2495689

SCHEMBL2495689

Cc1ccccc1N(CCO)C(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
LMNA P02545 2/20 0.37
TRPM8 Q7Z2W7 1/20 0.36
AOC3 Q16853 2/20 0.36
CYP2D6 P10635 2/20 0.36
HTR2A P28223 2/20 0.36
HRH1 P35367 2/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
ADRA2A P08913 1/20 0.36
CHRM1 P11229 1/20 0.36
ADRA2B P18089 1/20 0.36
CHRM3 P20309 1/20 0.36
DRD1 P21728 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495631 0.92 SLC6A2 (0.41) SLC6A2SLC6A4LMNATRPM8AOC3
SCHEMBL2492244 0.81 MEN1 (0.40) LMNAAOC3HTR2AHRH1TRPA1
SCHEMBL2490779 0.81 SLC6A2 (0.45) SLC6A2SLC6A4LMNAMEN1KMT2A
SCHEMBL7594235 0.78 KDM4E (0.42) SLC6A2SLC6A4LMNAHTR2AHRH1
SCHEMBL28434162 0.76 GAA (0.35) SLC6A2SLC6A4LMNATRPM8CYP2D6
SCHEMBL29421638 0.74 ALDH1A1 (0.47) SLC6A2SLC6A4LMNATRPM8CYP3A4
SCHEMBL94000 0.74 ALDH1A1 (0.47) SLC6A2SLC6A4LMNATRPM8CYP3A4
SCHEMBL2491891 0.73 MEN1 (0.39) LMNAAOC3HTR2AHRH1MEN1
SCHEMBL2492865 0.73 SLC6A2 (0.44) SLC6A2SLC6A4LMNAMEN1KMT2A
SCHEMBL11702654 0.72 ALDH1A1 (0.45) SLC6A2SLC6A4LMNATRPM8CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH SLC6A2 709/4885SLC6A4 1710/4885LMNA 2547/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 SLC6A2 641/4885SLC6A4 1431/4885LMNA 2843/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R SLC6A2 683/4885SLC6A4 1496/4885LMNA 2187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.